NSETrading Window30 Jun 2026 · 30 Jun 2026, 12:58 pm
Trading Window
Beta Drugs Limited · BETA
✦ AI Summary
Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
BETA_30062026125828_trading_window_letter.pdf
View document text
The Manager
Listing Department
National Stock Exchange of India Limited
Exchange Plaza, C-1, Block-G
Bandra Kurla Complex
Bandra East
Mumbai 400051
Script:-BETA
Dear Sir,
Subject: Intimation of Closure of Trading Window
Pursuant to circular of National Stock Exchange of India Limited vide reference No. NSE/CML/2019/11
dated 2nd April, 2019 on “ Clarification regarding Trading restriction period” SEBI (Prohibition of Insider
Trading) Regulation, 2015 and in terms of the company’s “Code for Prevention of Insider Trading” we
wish to inform you that the Trading Window for trading in the securities of the company shall remain
closed for all the Directors, Officers, Designated Employees, their immediate relatives and all other
covered under the code from 1st July, 2026 till 48 hours after the declaration of Un-Audited Financial
Results for the 1st Quarter ended 30th June, 2026.
Kindly take the above information on your record.
Thanking You
Your’s faithfully
For Beta Drugs Ltd.
Rajni Brar
Company Secretary